Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders, announced positive 6-month follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback